Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 18, 2019Understand AD program brings together a team of experts to help a teen with severe atopic dermatitis (AD) and his parents navigate the disease
-
Sep 16, 2019- Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin
-
Aug 28, 2019Court rules in favor of Sanofi and Regeneron in ongoing Praluent® (alirocumab) patent litigation
-
Aug 20, 2019- Appoints Dr. Sherron Kell as SVP of Clinical Development and Program Lead for PRV-031 (Teplizumab) -
-
Aug 8, 2019-Bispecific Diabody Designed to Intercept B-Cell Mediated Autoimmune Diseases-
-
Aug 6, 2019U.S. FDA submission for children planned for 4Q 2019
-
Aug 6, 2019PRV-031 Granted Breakthrough Therapy Designation for the Delay or Prevention of Clinical Type 1 Diabetes in At-Risk Individuals
